Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02217891 · ClinicalTrials.gov registry record
IFACT: Incidental Findings in Advanced Cancer Therapy
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 60
- Enrollment target
NCT02217891: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02217891 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02217891 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The proposed study, IFACT - Incidental Findings in Advanced Cancer Therapy, will address this research gap by examining MSK patients' attitudes, preferences, and information needs regarding incidental findings arising from tumor genomic profiling.
Interventions
- BEHAVIORAL Semi-structured interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-08 |
| Est. Completion | 2023-02-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02217891
The ClinicalTrials.gov registry entry for NCT02217891 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Semi-structured interview is the first listed.
NCT02217891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02217891 about?
NCT02217891 is a clinical study titled "IFACT: Incidental Findings in Advanced Cancer Therapy". The proposed study, IFACT - Incidental Findings in Advanced Cancer Therapy, will address this research gap by examining MSK patients' attitudes, preferences, and information needs regarding incidental findings arising from tumor genomic profiling.
What is the current status of trial NCT02217891?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2014-08. Estimated completion is 2023-02-09.
What interventions are being tested in trial NCT02217891?
The interventions under investigation include: Semi-structured interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT02217891?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.